Search

Your search keyword '"Biological response modifiers -- Forecasts and trends"' showing total 10 results
Start Over Descriptor "Biological response modifiers -- Forecasts and trends" Topic general interest
10 results on '"Biological response modifiers -- Forecasts and trends"'

1. Interferon Alpha-2a Biosimilar Market Report 2019-2024

Subjects
Biological response modifiers -- Forecasts and trends, Business research -- Forecasts and trends, Interferon alpha -- Forecasts and trends, Lysine, Decision making, Antiviral agents, Interferon, DNA, Technology, Market trend/market analysis, General interest
Abstract

New Delhi, April 11 -- The latest trending report Global Interferon Alpha-2a Biosimilar Market by Manufacturers, Regions, Type and Application, Forecast to 2024 offered by DecisionDatabases.com is an informative study [...]

Published
2019

2. Interferon Market In-Depth Research Report by Top Key Players and Demands

Subjects
Biological response modifiers -- Forecasts and trends, Interferon -- Forecasts and trends, Market trend/market analysis, General interest
Abstract

India, Oct. 25 -- 25th October, 2018- Interferon Market expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across [...]

Published
2018

3. Interferon Market In-Depth Research Report by Top Key Players and Demands

Subjects
Biological response modifiers -- Forecasts and trends, Interferon -- Forecasts and trends, Market trend/market analysis, General interest
Abstract

India, Oct. 25 -- Interferon Market expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Interferon [...]

Published
2018

4. World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others) 2013-2017

Subjects
Erythropoietin -- Forecasts and trends, Interferon alpha -- Forecasts and trends, Biological response modifiers -- Forecasts and trends, Insulin -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Jul 23, 2014 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/tpvpdw/the_world_market) has announced the addition of the 'The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon [...]

Published
2014

5. The World Market for Biosimilars 2013-2017 - EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies

Subjects
Erythropoietin -- Forecasts and trends, Interferon alpha -- Forecasts and trends, Biological response modifiers -- Forecasts and trends, Insulin -- Forecasts and trends, Monoclonal antibodies -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Jun 06, 2014 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/7brbq6/the_world_market) has announced the addition of the 'The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal [...]

Published
2014

6. World Market for Biosimilars to 2017: EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others

Subjects
Erythropoietin -- Forecasts and trends, Generic drugs -- Forecasts and trends, Interferon alpha -- Forecasts and trends, Biological response modifiers -- Forecasts and trends, Insulin -- Forecasts and trends, Monoclonal antibodies -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

Apr 16, 2014 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/5qb5x5/the_world_market) has announced the addition of the 'The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon [...]

Published
2014

7. Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Subjects
Interferon -- Product introduction -- Forecasts and trends, Multiple sclerosis -- Forecasts and trends, Biological response modifiers -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Avonex (Medication) -- Product introduction
Abstract

May 15, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/zk5xkd/avonex_multiple) has announced the addition of the 'Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

Published
2013

8. Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Subjects
Interferon -- Product introduction -- Forecasts and trends, Multiple sclerosis -- Forecasts and trends, Biological response modifiers -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Betaseron (Medication) -- Product introduction, Betaferon (Medication) -- Product introduction
Abstract

May 15, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/wc4bng/betaseronbetafero) has announced the addition of the 'Betaseron/Betaferon (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

Published
2013

9. NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Subjects
Interferon -- Product introduction -- Forecasts and trends, Multiple sclerosis -- Forecasts and trends, Biological response modifiers -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

May 14, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/4t9gzl/nu100_multiple) has announced the addition of the 'NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

Published
2013

10. Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Subjects
Interferon beta -- Forecasts and trends, Multiple sclerosis -- Forecasts and trends, Biological response modifiers -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary, Rebif (Medication) -- Product introduction
Abstract

May 14, 2013 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/rf3vwm/rebif_multiple) has announced the addition of the 'Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022' report to [...]

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results